Challenges and opportunities for IBD drug development: from early stage to regulatory approval

Silvio Danese, Elmer Schabel, Mark Andrew Ainsworth, Laurent Peyrin-Biroulet

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1157-1161
Number of pages5
JournalGut
Volume69
Issue number7
DOIs
Publication statusPublished - Jul 2020

Cite this